Medication info
Glopozone 5/80 mg

Glopozone 5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
Dark yellow, round film-coated tablet
Packaging
28 tablets (14 tablets x 2 blisters)
Approval status
Active

MFDS item code 201404977 · Approved 2014.10.28 · Insurance code 693201190

Summary

Main use
Treatment of essential hypertension inadequately controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time every day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before treatment with this drug. However, a direct switch to this drug may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows. · 5/80 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. · 5/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. · 10/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this drug to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Exercise caution when increasing the dose.
Child dose
Pediatric patients under 18 years of age: The administration of this drug is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively control blood pressure in patients with essential hypertension who have difficulty controlling their blood pressure with monotherapy using amlodipine or valsartan.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time every day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before treatment with this drug. However, a direct switch to this drug may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows. · 5/80 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. · 5/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. · 10/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this drug to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Exercise caution when increasing the dose.

Child dose

Pediatric patients under 18 years of age: The administration of this drug is not recommended because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm or even death to the fetus and newborn if taken during the second or third trimesters of pregnancy; therefore, it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients of this medication or to similar classes of medications, women who are pregnant or breastfeeding, and patients with severe renal or hepatic impairment should not take this medication. Patients with low sodium or fluid levels may experience hypotension, so it is important to carefully check conditions before taking the medication and to monitor blood pressure closely during treatment. Patients with high potassium levels or those taking potassium supplements should regularly monitor their potassium levels, and patients with renal issues or kidney transplant recipients should use this medication with caution. This medication can cause a serious side effect called angioedema, so if swelling of the face, lips, tongue, or difficulty breathing occurs, the medication should be discontinued immediately and medical attention should be sought. Patients with heart failure or myocardial infarction may be affected in their kidney function by taking this medication, so regular kidney function tests must be conducted. This medication can interact with other antihypertensive drugs, certain diuretics, potassium-sparing drugs, and non-steroidal anti-inflammatory drugs (NSAIDs); therefore, it is important to inform your doctor or pharmacist of any other medications being taken. Caution should be taken as dizziness or fatigue may occur while driving or operating machinery. Standard dosages are recommended for the elderly, but kidney or liver function should be carefully monitored during treatment. Overdosing can lead to severe hypotension or cardiac problems, so it is vital to adhere to the prescribed dosage, and if an overdose is suspected, seek medical assistance immediately.

Side effects

  • Nasopharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • headache
  • dizziness
  • drowsiness
  • position-related dizziness
  • paresthesia
Show 108 more
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pharyngeal and laryngeal pain
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • thirst
  • rash
  • erythema
  • hyperhidrosis
  • rash
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle spasms
  • lethargy
  • polyuria
  • urinary frequency
  • erectile dysfunction
  • edema
  • peripheral edema
  • face edema
  • peripheral edema
  • fatigue
  • flushing
  • asthenia
  • facial flushing
  • decreased hemoglobin
  • decreased hematocrit
  • neutropenia
  • thrombocytopenia
  • serum sickness
  • increased serum potassium
  • vasculitis
  • elevated liver function tests
  • angioedema
  • myalgia
  • renal failure
  • kidney injury
  • elevated serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory infection
  • viral infection
  • double vision
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • sensory loss
  • taste disturbances
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • dysuria
  • nocturia
  • gynecomastia
  • pain
  • malaise
  • chest pain
  • weight loss
  • weight gain
  • elevated liver enzymes
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux disease
  • neck pain
  • hypercholesterolemia
  • hypoglycemia
  • neuroirritability
  • Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and stored at room temperature between 1 to 30 degrees Celsius to ensure its effectiveness over time.

Appearance and packaging

Appearance

Dark yellow, round film-coated tablet

Package unit

28 tablets (14 tablets x 2 blisters)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.